Package 65219-596-01

Brand: tyenne

Generic: tocilizumab-aazg
NDC Package

Package Facts

Identity

Package NDC 65219-596-01
Digits Only 6521959601
Product NDC 65219-596
Product ID 65219-596_87ac5047-4f2b-4571-a8a8-32e08865f379
Description

1 SYRINGE, GLASS in 1 CARTON (65219-596-01) / .9 mL in 1 SYRINGE, GLASS

Marketing

Marketing Status
Marketed Since 2025-09-01
Brand tyenne
Generic tocilizumab-aazg
Sample Package No

Linked Drug Pages (1)

TYENNE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "87ac5047-4f2b-4571-a8a8-32e08865f379", "openfda": {"nui": ["N0000190478", "N0000190480"], "unii": ["I031V2H011"], "rxcui": ["2686045", "2686050", "2686053", "2686057"], "spl_set_id": ["87ac5047-4f2b-4571-a8a8-32e08865f379"], "pharm_class_epc": ["Interleukin-6 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Interleukin 6 Receptor Antagonists [MoA]"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, GLASS in 1 CARTON (65219-596-01)  / .9 mL in 1 SYRINGE, GLASS", "package_ndc": "65219-596-01", "marketing_start_date": "20250901"}], "brand_name": "TYENNE", "product_id": "65219-596_87ac5047-4f2b-4571-a8a8-32e08865f379", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Interleukin 6 Receptor Antagonists [MoA]", "Interleukin-6 Receptor Antagonist [EPC]"], "product_ndc": "65219-596", "generic_name": "Tocilizumab-aazg", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TYENNE", "active_ingredients": [{"name": "TOCILIZUMAB", "strength": "162 mg/.9mL"}], "application_number": "BLA761449", "marketing_category": "BLA", "marketing_start_date": "20250901", "listing_expiration_date": "20261231"}